| scholarly article | Q13442814 |
| P50 | author | Robert Andres | Q96114623 |
| P2093 | author name string | Hui Wang | |
| Abhijit De | |||
| Sanjiv S Gambhir | |||
| Brian K Rutt | |||
| Raphael Guzman | |||
| Arjun V Pendharkar | |||
| Nancy Wang | |||
| Raymond Choi | |||
| Xavier Gaeta | |||
| Shawn Chen | |||
| Josh Y Chua | |||
| P2860 | cites work | Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial | Q42483132 |
| The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
| Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling | Q44403591 | ||
| Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia | Q44972813 | ||
| Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke | Q45042816 | ||
| Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke | Q46438887 | ||
| The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats | Q46524695 | ||
| Intravenous versus intrastriatal cord blood administration in a rodent model of stroke | Q48251138 | ||
| Comparison of two neonatal ischemic injury models using magnetic resonance imaging | Q48315628 | ||
| Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | Q48332405 | ||
| Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats | Q48721941 | ||
| Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. | Q49087443 | ||
| Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues | Q79148116 | ||
| Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect | Q24635138 | ||
| Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats | Q28209989 | ||
| Multipotent neural cell lines can engraft and participate in development of mouse cerebellum | Q28290006 | ||
| Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat | Q30160203 | ||
| Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia | Q33322707 | ||
| Intravenous mesenchymal stem cell therapy for traumatic brain injury | Q33929697 | ||
| Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 | ||
| Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke | Q34468850 | ||
| Cell transplantation therapy for stroke | Q36721703 | ||
| Neural stem/precursor cells for the treatment of ischemic stroke. | Q36870255 | ||
| Intravascular cell replacement therapy for stroke | Q37110216 | ||
| Potential of adult neural stem cells in stroke therapy | Q37306810 | ||
| Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. | Q37416265 | ||
| Challenges and possibilities of intravascular cell therapy in stroke. | Q37424810 | ||
| Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model | Q40007652 | ||
| Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset | Q40058832 | ||
| Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects | Q40149368 | ||
| In vivo magnetic resonance imaging of single cells in mouse brain with optical validation | Q40341234 | ||
| Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke | Q40530106 | ||
| Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer | Q41741592 | ||
| Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke | Q42473897 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neural stem cell | Q2944097 |
| hypoxia | Q105688 | ||
| P304 | page(s) | 2064-2070 | |
| P577 | publication date | 2010-07-08 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia | |
| P478 | volume | 41 |
| Q37372190 | A novel method for efficient delivery of stem cells to the ischemic brain |
| Q35738018 | A possible new focus for stroke treatment - migrating stem cells |
| Q34290126 | A randomized trial of mesenchymal stem cells in multiple system atrophy. |
| Q30846905 | A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in stroke |
| Q28066235 | Adult Stem Cell Therapy for Stroke: Challenges and Progress |
| Q48286251 | Amelioration of Penetrating Ballistic-Like Brain Injury Induced Cognitive Deficits after Neuronal Differentiation of Transplanted Human Neural Stem Cells. |
| Q57811761 | Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study |
| Q39018663 | BDNF Pretreatment of Human Embryonic-Derived Neural Stem Cells Improves Cell Survival and Functional Recovery After Transplantation in Hypoxic-Ischemic Stroke |
| Q37905334 | Bioluminescence imaging: progress and applications |
| Q27316440 | Boosting bioluminescence neuroimaging: an optimized protocol for brain studies |
| Q26866330 | Brain repair: cell therapy in stroke |
| Q43207208 | Canine adipose-derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints |
| Q47833142 | Cell Therapy in Stroke-Cautious Steps Towards a Clinical Treatment. |
| Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
| Q50209524 | Cell-Based Therapy in TBI: Magnetic Retention of Neural Stem Cells In Vivo |
| Q26776494 | Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic Stroke |
| Q34238869 | Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis. |
| Q43140839 | Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats. |
| Q37682331 | Comparison of MSC-Neurogenin1 administration modality in MCAO rat model |
| Q37361576 | Contralaterally transplanted human embryonic stem cell-derived neural precursor cells (ENStem-A) migrate and improve brain functions in stroke-damaged rats |
| Q37871429 | Current challenges for the advancement of neural stem cell biology and transplantation research. |
| Q33694696 | Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke |
| Q89134972 | Effective Treatment of Traumatic Brain Injury in Rowett Nude Rats with Stromal Vascular Fraction Transplantation |
| Q36997873 | Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke |
| Q33577748 | Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model |
| Q47096921 | Efficacy of Two Delivery Routes for Transplanting Human Neural Progenitor Cells (NPCs) Into the Spastic Han-Wistar Rat, a Model of Ataxia |
| Q37578064 | Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model : comparison of intra-arterial and intravenous infusion using MRI and histological analysis |
| Q40797718 | Evaluation of engraftment of superparamagnetic iron oxide-labeled mesenchymal stem cells using three-dimensional reconstruction of magnetic resonance imaging in photothrombotic cerebral infarction models of rats |
| Q30771799 | Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies |
| Q40269191 | Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery |
| Q38753414 | Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. |
| Q88401090 | Intra-Arterial Delivery of Cell Therapies for Stroke |
| Q35895283 | Intra-arterial delivery of cell therapies for stroke |
| Q35396013 | Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats |
| Q33771764 | Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes |
| Q44014320 | Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke. |
| Q30840750 | Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities |
| Q42314752 | Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function |
| Q38303586 | Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease |
| Q38648551 | Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors |
| Q36861449 | Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma |
| Q37854671 | Intranasal delivery of stem cells to the brain |
| Q38170033 | Intravascular stem cell transplantation for stroke |
| Q48612634 | Intravenously Infused F3.Olig2 Improves Memory Deficits via Restoring Myelination in the Aged Hippocampus Following Experimental Ischemic Stroke |
| Q50042694 | Magnetic Resonance and Photoacoustic Imaging of Brain Tumor Mediated by Mesenchymal Stem Cell-Labeled with Multifunctional Nanoparticle Introduced via Carotid Artery Injection |
| Q64102532 | Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress |
| Q64075687 | Mesenchymal Stromal Cell Derived Extracellular Vesicles Reduce Hypoxia-Ischaemia Induced Perinatal Brain Injury |
| Q30435527 | Neural progenitor cells labeling with microbubble contrast agent for ultrasound imaging in vivo |
| Q53757262 | Neural stem cell therapies and hypoxic-ischemic brain injury. |
| Q36964182 | Neuroprotective effects of systemic cerebral endothelial cell transplantation in a rat model of cerebral ischemia |
| Q34505528 | Non-invasive imaging of endothelial progenitor cells in tumor neovascularization using a novel dual-modality paramagnetic/near-infrared fluorescence probe |
| Q26776154 | Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease |
| Q38225145 | Radiopharmaceutical stem cell tracking for neurological diseases |
| Q37864499 | Regenerative medicine for stroke - are we there yet? |
| Q38662225 | Rehabilitation and the Neural Network After Stroke |
| Q55665217 | Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method. |
| Q57288362 | Stem Cell Therapy in Cerebrovascular Disease |
| Q38903653 | Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration |
| Q26861615 | Stem cell imaging: from bench to bedside |
| Q38369063 | Stem cell transplantation enhances endogenous brain repair after experimental stroke |
| Q34923168 | Stem cells and stroke: opportunities, challenges and strategies |
| Q38157667 | Stem cells for brain repair in neonatal hypoxia-ischemia |
| Q38019968 | Stem cells in stroke treatment: the promise and the challenges. |
| Q38402505 | Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling |
| Q36020853 | The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain |
| Q36523465 | The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke |
| Q50561689 | The effects of fibroblast growth factor-2 and pluripotent astrocytic stem cells on cognitive function in a rat model of neonatal hypoxic-ischemic brain injury. |
| Q38081017 | The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. |
| Q61806270 | The spleen may be an important target of stem cell therapy for stroke |
| Q34202309 | Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy |
| Q36247838 | Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor |
Search more.